No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ELTX Elicio Therapeutics
- 5.620
- +0.480+9.34%
Close Jan 3 16:00 ET
60.65MMarket Cap-1.29P/E (TTM)
5.657High5.140Low48.26KVolume5.430Open5.140Pre Close261.16KTurnover0.57%Turnover RatioLossP/E (Static)10.79MShares11.45052wk High-3.19P/B47.27MFloat Cap2.96052wk Low--Dividend TTM8.41MShs Float263.000Historical High--Div YieldTTM10.06%Amplitude2.960Historical Low5.411Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Elicio Therapeutics Advances ELI-002 and Secures Funding
Elicio Therapeutics Presents Updated Results From ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024
Elicio Therapeutics Announces Completion of Phase 2 AMPLIFY-7P Study Enrollment
Express News | Elicio Therapeutics Announces Completion of Phase 2 Amplify-7P Study Enrollment
Express News | Elicio Therapeutics Inc: Expects Current Cash and Cash Equivalents to Support Operations Into Q2 of 2025
Elicio Therapeutics Q3 2024 GAAP EPS $(1.39) Misses $(0.73) Estimate
Heat List
US
Overall
Symbol
Price
% Chg
No Data